ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,683Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 16

$425K Total Retail Price of All Prescriptions

Rank: 3 out of 16

485 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 485 patients filled at least one prescription for a schedule two drug, compared to an average of 17%.

Schedule Three
Controlled Substances

6% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 9,917 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $44 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LEVOTHYROXINE SODIUM 524 498 1 1
WARFARIN SODIUM 424 377 2 5
FUROSEMIDE 385 376 3 2
TRAZODONE HCL 326 308 4 12
OMEPRAZOLE 314 293 5 6
LISINOPRIL 304 298 6 4
CITALOPRAM HBR 286 262 7 3
POTASSIUM CHLORIDE 266 263 8 13
METOPROLOL TARTRATE 265 255 9 7
GABAPENTIN 237 215 10 10
AMLODIPINE BESYLATE 213 201 11 9
SERTRALINE HCL 196 192 12 19
HALOPERIDOL 194 185 13 41
DIVALPROEX SODIUM 194 186 13 24
ATENOLOL 176 176 15 18
POLYETHYLENE GLYCOL 3350 167 166 16 11
SIMVASTATIN 165 153 17 8
RISPERIDONE 159 158 18 31
DONEPEZIL HCL 132 129 19 14
ALBUTEROL SULFATE 131 126 20 34
TRAMADOL HCL 127 126 21 29
METFORMIN HCL 124 109 22 33
METOPROLOL SUCCINATE 123 109 23 16
HYDROCHLOROTHIAZIDE 110 110 24 21
CYMBALTA 102 84 25 43
LANTUS 98 91 26 30
PREDNISONE 94 94 27 23
ALLOPURINOL 91 91 28 44
PAROXETINE HCL 83 81 29 53
VENLAFAXINE HCL 80 71 30 75
NAMENDA 80 80 30 20
NYSTATIN 79 74 32 36
RAMIPRIL 76 75 33 59
QUETIAPINE FUMARATE 72 60 34 27
MIRTAZAPINE 71 71 35 17
VENLAFAXINE HCL ER 71 71 35 66
NOVOLOG 69 58 37 37
CARBIDOPA-LEVODOPA 68 68 38 35
ESCITALOPRAM OXALATE 65 61 39 79
CARVEDILOL 65 53 39 38
LOSARTAN POTASSIUM 64 61 41 39
GLIPIZIDE 63 48 42 75
BACLOFEN 59 35 43 102
OXYCODONE HCL 58 58 S2 44 15
LEVETIRACETAM 57 40 45 51
TAMSULOSIN HCL 57 36 45 32
OLANZAPINE 56 42 47 50
DIGOXIN 56 56 47 48
LIDODERM 52 51 49 69
RANITIDINE HCL 50 50 50 22
ISOSORBIDE MONONITRATE ER 50 50 50 46
FAMOTIDINE 50 50 50 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.